What's breaking now, across thousands of outlets.
Kodiak Sciences appears to have an Eylea successor on its hands. The Silicon Valley biotech said its experimental drug Zenkuda performed as well as Eylea in a progressive eye disease known as wet age-related macular ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(RTTNews) - Redcare Pharmacy N.V. (SAE1.F) on Monday raised its full-year 2026 revenue guidance for the second time this year, citing continued strong momentum in prescription (Rx) revenue in Germany.
UBS has vowed to keep opposing the plans
The AAP had disclosed ₹38.10 crore in contributions in 2024-25, more than three times the ₹11.06 crore it reported in 2023-24. Prudent was its largest donor in 2024-25, giving ₹16.40 crore.
The 43% of scam victims who pay fraudsters within an hour present banks with an obvious problem. There may be almost no time to stop the transaction.
EUR/USD trades on the back foot on Monday, pressured by a stronger US Dollar (USD) as the US-Iran stalemate keeps Oil prices elevated, pushing US Treasury yields higher and strengthening expectations…
